BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 27, 2019

View Archived Issues

Indirect targeting can affect serine production

Read More

Thai vaccine works better in South Africa

Read More

Targeting genes while avoiding their homologues can fix CGD

Read More

Lymphocytes check brain's privilege

Read More

NR4A1AS lncRNA regulates NR4A1 expression promoting colorectal cancer tumor growth and metastasis

Read More

DG-12P1 identified as first AI-discovered therapeutic candidate

Read More

Inflazome begins first-in-human study of IZD-334 for CAPS

Read More

New phase I trial of IGM-2323 enrolling patients with relapsed or refractory B-cell NHL

Read More

Study reports new insight into, target for Krabbe disease

Read More

BAL-101553 treatment associated with inhibition of CSLC-mediated tumor angiogenesis in vivo

Read More

Dual CB1R/iNOS antagonist MRI-1867 ameliorates obesity-induced CKD in vivo

Read More

FABP4 as a novel biochemical marker in diabetic ketoacidosis in children

Read More

TRPC4AP identified as gene biomarker candidate in thyroid dysgenesis

Read More

FDA authorizes first-in-human clinical trial of AZD-0466

Read More

First patient dosed in phase IIb ICONA study of icosabutate

Read More

Immunicum presents complete topline data from phase II MERECA study

Read More

Immutep announces positive interim data from TACTI-002 phase II study

Read More

GlaxoSmithKline and ViiV Healthcare patent new compounds for HIV

Read More

Zeno Royalties & Milestones presents WEE1hu inhibitors

Read More

Amgen identifies Mcl-1 inhibitors

Read More

Pliant Therapeutics describes integrin alphavbeta6 antagonists

Read More

New TYK2 inhibitors detailed in AbbVie patent

Read More

FDA approves Jynneos for prevention of smallpox and monkeypox disease in adults

Read More

Clinical phase IIa data on RNS-60 for multiple sclerosis presented

Read More

NIDA award to support Ensysce's development of opioid use disorder product

Read More

Phase II study of ganaxolone in refractory status epilepticus meets primary endpoint

Read More

Galmed initiates phase III/IV study of aramchol in patients with NASH and fibrosis

Read More

Curevo reports preliminary phase I data on shingles vaccine candidate CRV-101

Read More

European Commission approves Trogarzo for HIV-1

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing